• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PHILIPS ELECTRONICS LTD. PHILIPS DREAM STATION BI-PAP; VENTILATOR, NON-CONTINUOUS (RESPIRATOR)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PHILIPS ELECTRONICS LTD. PHILIPS DREAM STATION BI-PAP; VENTILATOR, NON-CONTINUOUS (RESPIRATOR) Back to Search Results
Device Problems Nonstandard Device (1420); Contamination /Decontamination Problem (2895)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/01/2021
Event Type  malfunction  
Event Description
I have a philips bi-pap machine and have met all their recall info.My dr says due to the severity of my problem.I should continue using it.However i have noticed over the last 3 months that the filters are getting darker and darker, i have photos that you should see.The actual filter itself had a residue on it which i scraped off and still have.I'm very concerned by this due to the recall.Looking forward to your response (b)(6).Fda safety report id# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PHILIPS DREAM STATION BI-PAP
Type of Device
VENTILATOR, NON-CONTINUOUS (RESPIRATOR)
Manufacturer (Section D)
PHILIPS ELECTRONICS LTD.
MDR Report Key12953521
MDR Text Key281928583
Report NumberMW5105857
Device Sequence Number1
Product Code BZD
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 12/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/06/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Was Device Available for Evaluation? Yes
Patient Sequence Number1
Treatment
ATORVASTATIN ; FISH OIL ; VITAMINS B, C, D, E
Patient Age62 YR
Patient SexMale
Patient Weight100 KG
Patient RaceWhite
-
-